$SCL

Stepan (NYSE: SCL) aims to achieve $100M in savings through its Project Catalyst initiative, with 60% expected in 2026. The company reported high-single-digit growth in oilfield chemicals and a threefold increase in rigid and spray-foam insulation business. Stepan has reduced net leverage to 2.5x and expects positive cash generation for the year.

Strategic Performance Drivers Adjusted EBITDA growth of 45% was driven by a combination of 6% organic volume growth, disciplined pricing execution, and ramping productivity gains. Surfactant performance benefited from broad-based demand across all end markets, specifically led by industrial cleaning, laundry, and oil field sectors. Margin recovery was achieved through the rigorous application of contractual pass-through mechanisms and pricing actions to offset fluctuating raw material costs.

Stepan (NYSE: SCL) reported Q2 2026 net income of $22.9M, up 102% year over year, and adjusted net income of $27.1M, up 126%. Adjusted EBITDA rose 45% to $74.4M. Net sales increased 15% to $684.1M, with organic volume up 6%. Free cash flow was -$15.0M due to working capital. The company plans to cut about 100 salaried roles under Project Catalyst and expects full-year restructuring charges of $75.0M-$80.0M.

STEPAN CO (SCL) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Stepan Reports Second Quarter 2026 Results Northbrook, Illinois, July 29, 2026 — Stepan Company (NYSE: SCL) today reported: Second Quarter 2026 Highlights • Reported net income was $22.9 million, up 102% versus the prior year. Adjusted net income (1) was $27.1 millio

Stepan Company (NYSE: SCL) will release its second-quarter 2026 earnings on July 29, 2026 at about 7:00 a.m. ET, with investor slides posted the same time. The company will host a conference call at 9:00 a.m. ET led by CEO Luis E. Rojo and CFO Ruben Velasquez, with a webcast and replay available.

NZX50 was down 0.3% at 3:00pm, though up 0.4% over five sessions and 6.5% over 12 months. Gentrack Group led gainers (+4%), while Vista Group fell the most (-3%). Ebos (-3%) and A2 Milk (-1%) also declined. Ryman Healthcare is considering new six-year secured bonds; Scales Corp declared a 12.5c FY2025 final dividend; Pacific Edge raised NZ$36.1m at NZ$0.17/share.

Sands China Ltd. said in an internal memo reviewed by The Times that Hubert Wang, formerly MGM China’s president and COO, will become Sands China’s new COO effective today. He will oversee gaming and resort operations, market and international marketing, loyalty marketing, strategic analysis and operations. The memo cites his 30+ years’ experience. Separately, Las Vegas Sands’ Rob Goldstein sold about 250,000 shares for about USD12.8m, per an SEC filing.

The NZX50 rose 0.7% to extend gains to 3.1% over five days and 3.1% for the month (still down 2.0% over six months; up 4.6% YoY). Kathmandu Holdings jumped 14% and KMD reported Q3 FY26 sales +5.2% YoY and gross margin 58.2% (+258 bps). Vista Group gained 4% on a new five-year Cinemex deal; PaySauce revenue rose 3% to $9.2m.

Stepan Company's VP and GM Surfactants-INT, Robin Joseph Weitkamp, reported the vesting of 90 Restricted Stock Units (RSUs) on May 11, 2026. To cover tax obligations, 50 shares of common stock, valued at $52.58 each, were withheld. After these transactions, Weitkamp directly holds 40 shares and indirectly holds 96.9 shares through the ESOP II Trust.

Stepan Company (NYSE: SCL) has declared a quarterly cash dividend of $0.395 per share, payable on March 13, 2026, to shareholders of record on March 2, 2026. This marks the 58th consecutive year the company has increased its dividend, following a $0.010 per share increase in Q4 2025. Despite this consistent increase, the stock experienced a significant negative market reaction, declining 20.38% on the day this news was published, resulting in a $352 million reduction in the company's valuation.